Benzinga | Feb 8, 2021 06:47AM EST

HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $5.5

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price target from $9 to $5.5.